CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) Total expenses

Annual total expenses:

$327.85M+$1.05M(+0.32%)
December 31, 2024

Summary

  • As of today (September 10, 2025), CPRX annual total expenses is $327.85 million, with the most recent change of +$1.05 million (+0.32%) on December 31, 2024.
  • During the last 3 years, CPRX annual total expenses has risen by +$226.49 million (+223.47%).
  • CPRX annual total expenses is now at all-time high.

Performance

CPRX Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Quarterly total expenses:

$94.45M+$9.77M(+11.54%)
June 30, 2025

Summary

  • As of today (September 10, 2025), CPRX quarterly total expenses is $94.45 million, with the most recent change of +$9.77 million (+11.54%) on June 30, 2025.
  • Over the past year, CPRX quarterly total expenses has increased by +$12.54 million (+15.31%).
  • CPRX quarterly total expenses is now -29.22% below its all-time high of $133.45 million, reached on September 30, 2023.

Performance

CPRX Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

CPRX Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+0.3%+15.3%
3 y3 years+223.5%+199.9%
5 y5 years+365.5%+376.4%

CPRX Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+223.5%-29.2%+199.9%
5 y5-yearat high+643.6%-29.2%+773.6%
alltimeall timeat high>+9999.0%-29.2%+773.6%

CPRX Total expenses History

DateAnnualQuarterly
Jun 2025
-
$94.45M(+11.5%)
Mar 2025
-
$84.68M(-1.4%)
Dec 2024
$327.85M(+0.3%)
$85.88M(+1.3%)
Sep 2024
-
$84.81M(+3.5%)
Jun 2024
-
$81.92M(+8.9%)
Mar 2024
-
$75.23M(-0.6%)
Dec 2023
$326.79M(+149.2%)
$75.72M(-43.3%)
Sep 2023
-
$133.45M(+115.9%)
Jun 2023
-
$61.82M(+10.8%)
Mar 2023
-
$55.80M(+58.1%)
Dec 2022
$131.12M(+29.4%)
$35.29M(+2.3%)
Sep 2022
-
$34.50M(+9.5%)
Jun 2022
-
$31.49M(+5.5%)
Mar 2022
-
$29.85M(+2.9%)
Dec 2021
$101.35M(+129.9%)
$29.00M(+13.2%)
Sep 2021
-
$25.63M(+6.0%)
Jun 2021
-
$24.18M(+7.3%)
Mar 2021
-
$22.54M(+15.1%)
Dec 2020
$44.09M(-37.4%)
$19.58M(-239.6%)
Sep 2020
-
-$14.02M(-170.7%)
Jun 2020
-
$19.82M(+6.0%)
Mar 2020
-
$18.71M(-15.7%)
Dec 2019
$70.43M(+104.1%)
$22.19M(+28.5%)
Sep 2019
-
$17.27M(-3.4%)
Jun 2019
-
$17.88M(+36.5%)
Mar 2019
-
$13.09M(-12.7%)
Dec 2018
$34.50M(+87.4%)
$15.00M(+91.3%)
Sep 2018
-
$7.84M(+31.4%)
Jun 2018
-
$5.97M(+4.7%)
Mar 2018
-
$5.70M(+5.8%)
Dec 2017
$18.41M(+1.9%)
$5.39M(+29.0%)
Sep 2017
-
$4.18M(+7.7%)
Jun 2017
-
$3.88M(-21.9%)
Mar 2017
-
$4.97M(+19.3%)
Dec 2016
$18.07M(-10.7%)
$4.16M(+5.3%)
Sep 2016
-
$3.95M(-13.5%)
Jun 2016
-
$4.57M(-15.2%)
Mar 2016
-
$5.39M(-7.4%)
Dec 2015
$20.23M
$5.82M(+30.7%)
Sep 2015
-
$4.45M(-2.4%)
DateAnnualQuarterly
Jun 2015
-
$4.56M(-15.7%)
Mar 2015
-
$5.41M(+55.0%)
Dec 2014
$15.51M(+27.6%)
$3.49M(-30.3%)
Sep 2014
-
$5.01M(+56.7%)
Jun 2014
-
$3.20M(-16.1%)
Mar 2014
-
$3.81M(+181.3%)
Dec 2013
$12.15M(+198.2%)
$1.35M(-77.1%)
Sep 2013
-
$5.91M(+88.1%)
Jun 2013
-
$3.14M(+80.2%)
Mar 2013
-
$1.74M(+2177.2%)
Dec 2012
$4.08M(-36.2%)
$76.60K(-97.1%)
Sep 2012
-
$2.62M(+806.8%)
Jun 2012
-
$289.10K(-73.5%)
Mar 2012
-
$1.09M(-53.7%)
Dec 2011
$6.39M(+59.5%)
$2.35M(+108.5%)
Sep 2011
-
$1.13M(-19.1%)
Jun 2011
-
$1.39M(-8.1%)
Mar 2011
-
$1.52M(+108.2%)
Dec 2010
$4.01M(-44.7%)
$728.80K(-19.4%)
Sep 2010
-
$904.00K(-32.0%)
Jun 2010
-
$1.33M(+27.1%)
Mar 2010
-
$1.04M(-10.1%)
Dec 2009
$7.24M(-31.5%)
$1.16M(-9.7%)
Sep 2009
-
$1.29M(-27.0%)
Jun 2009
-
$1.76M(-41.9%)
Mar 2009
-
$3.03M(-19.1%)
Dec 2008
$10.56M(+155.2%)
$3.75M(+31.3%)
Sep 2008
-
$2.86M(+20.1%)
Jun 2008
-
$2.38M(+50.1%)
Mar 2008
-
$1.58M(+67.6%)
Dec 2007
$4.14M(+51.7%)
$944.90K(+28.7%)
Sep 2007
-
$734.30K(-39.2%)
Jun 2007
-
$1.21M(-3.5%)
Mar 2007
-
$1.25M(+68.9%)
Dec 2006
$2.73M(+51.2%)
$741.20K(-43.9%)
Sep 2006
-
$1.32M(+270.1%)
Jun 2006
-
$357.00K
Dec 2005
$1.81M(+234.5%)
-
Dec 2004
$539.80K(+25.9%)
-
Dec 2003
$428.60K(+67.5%)
-
Dec 2002
$255.90K
-

FAQ

  • What is Catalyst Pharmaceuticals, Inc. annual total expenses?
  • What is the all time high annual total expenses for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. annual total expenses year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. quarterly total expenses?
  • What is the all time high quarterly total expenses for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. quarterly total expenses year-on-year change?

What is Catalyst Pharmaceuticals, Inc. annual total expenses?

The current annual total expenses of CPRX is $327.85M

What is the all time high annual total expenses for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high annual total expenses is $327.85M

What is Catalyst Pharmaceuticals, Inc. annual total expenses year-on-year change?

Over the past year, CPRX annual total expenses has changed by +$1.05M (+0.32%)

What is Catalyst Pharmaceuticals, Inc. quarterly total expenses?

The current quarterly total expenses of CPRX is $94.45M

What is the all time high quarterly total expenses for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high quarterly total expenses is $133.45M

What is Catalyst Pharmaceuticals, Inc. quarterly total expenses year-on-year change?

Over the past year, CPRX quarterly total expenses has changed by +$12.54M (+15.31%)
On this page